AIDS 2013-01-28

No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients.

Richa Singh, Neal Marshall, Colette J Smith, Carl J Reynolds, Ronan A Breen, Sanjay Bhagani, Ian Cropley, Susan Hopkins, Leonie Swaden, Margaret A Johnson, Marc C Lipman

文献索引：AIDS 27(3) , 481-4, (2013)

全文：HTML全文

摘要

Rifabutin has been substituted for rifampicin when treating tuberculosis (TB)/HIV coinfection. However, despite reports of anti-TB treatment failure and acquired rifamycin resistance, long-term clinical outcome data are lacking. Observational analyses performed in a UK TB/HIV cohort demonstrated no difference in severe adverse events, anti-TB treatment completion, relapse frequency or subsequent rifamycin resistance when rifampicin and rifabutin were compared, using different combinations of antiretroviral therapy. Our data support the wider use of rifabutin in TB/HIV coinfection.

相关化合物

  • 利福布汀
  • 利福霉素钠

相关文献：

Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.

2015-01-01

[J. Pharm. Biomed. Anal. 102 , 9-16, (2014)]

Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection.

2014-11-21

[World J. Gastroenterol. 20(43) , 16245-51, (2014)]

Genipin crosslinked ethyl cellulose-chitosan complex microspheres for anti-tuberculosis delivery.

2013-03-01

[Colloids Surf. B Biointerfaces 103 , 530-7, (2013)]

Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein.

2014-06-01

[Antimicrob. Agents Chemother. 58(6) , 3168-76, (2014)]

Rifabutin reduces systemic exposure of an antimalarial drug 97/78 upon co-administration in rats: An in-vivo &in-vitro analysis.

[Asian Pac. J. Trop. Med. 8 , 630-5, (2015)]

更多文献...